Año: 2022
Journal Impact Factor (JIF): 8.20
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ENDOCRINOLOGY & METABOLISM | SCIE | 13/145 | Q1 | T1 | D1 |
Año: 2022
Journal Citation Indicator (JCI): 1,830
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ENDOCRINOLOGY & METABOLISM | 10/184 | Q1 | T1 | D1 | 94,84 |
Año:
2022
CiteScore:
17,600
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 10/232 | Q1 | T1 | D1 |
| Internal Medicine | 7/140 | Q1 | T1 | D1 |
SJR año:
2022
Factor de Impacto:
3,349
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 6/245 | Q1 | T1 | D1 |
| Internal Medicine | 7/163 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| European Union's Horizon 2020 research and innovation programme via the Innovative Medicines Initiative 2 Joint Undertaking | 115881 |
| MRC | MR/R022259/1; MR/P023223/1; MR/R022259/1; MR/P023223/1 |
| Novo Nordisk Foundation | NNF18CC0034900 |
| Wellcome Trust | WT212625/Z/18/Z |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Nguyen-Tu, MS | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
| 2 | Harris, J | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
| 3 | Martinez-Sanchez, A | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
| 4 | Chabosseau, P | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
| 5 | Hu, M | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
| 6 | Georgiadou, E | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
| 7 | Pollard, A | MRC London Institute of Medical Sciences; AstraZeneca (England) |
| 8 | Otero, P | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
| 9 | Lopez-Noriega, L | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
| 10 | Leclerc, I | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
| 11 | Sakamoto, K | Novo Nordisk Ctr Basic Metab Res (Denmark) |
| 12 | Schmoll, D | Sanofi-Aventis (Germany) |
| 13 | Smith, DM | AstraZeneca (England) |
| 14 | Carling, D | MRC London Institute of Medical Sciences (England) |
| 15 | Lee Kong Chian School of Medicine; Imperial College London Division of Diabetes Endocrinology and Metabolism; Centre Hospitalier de l'Universite de Montreal Centre de Recherche (Singapore) |